100 related articles for article (PubMed ID: 23077229)
21. Incidence of retinal pigment epithelial tears after intravitreal ranibizumab injection for neovascular age-related macular degeneration.
Cunningham ET; Feiner L; Chung C; Tuomi L; Ehrlich JS
Ophthalmology; 2011 Dec; 118(12):2447-52. PubMed ID: 21872935
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial.
Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group
Ophthalmology; 2008 Sep; 115(9):1474-9, 1479.e1-6. PubMed ID: 18502512
[TBL] [Abstract][Full Text] [Related]
23. Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study.
Heier JS; Antoszyk AN; Pavan PR; Leff SR; Rosenfeld PJ; Ciulla TA; Dreyer RF; Gentile RC; Sy JP; Hantsbarger G; Shams N
Ophthalmology; 2006 Apr; 113(4):633.e1-4. PubMed ID: 16483659
[TBL] [Abstract][Full Text] [Related]
24. One-year results of a flexible regimen with ranibizumab therapy in macular degeneration: relationship with the number of injections.
Arias L; Roman I; Masuet-Aumatell C; Rubio MJ; Caminal JM; Catala J; Pujol O
Retina; 2011; 31(7):1261-7. PubMed ID: 21499194
[TBL] [Abstract][Full Text] [Related]
25. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study.
Silva R; Cachulo ML; Fonseca P; Bernardes R; Nunes S; Vilhena N; Faria de Abreu JR
Ophthalmologica; 2011; 226(3):110-8. PubMed ID: 21822000
[TBL] [Abstract][Full Text] [Related]
26. [Intravitreal ranibizumab for age-related macular degeneration].
Sørensen TL; Kemp H
Ugeskr Laeger; 2010 May; 172(22):1685-9. PubMed ID: 20525469
[TBL] [Abstract][Full Text] [Related]
27. HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration.
Singer MA; Awh CC; Sadda S; Freeman WR; Antoszyk AN; Wong P; Tuomi L
Ophthalmology; 2012 Jun; 119(6):1175-83. PubMed ID: 22306121
[TBL] [Abstract][Full Text] [Related]
28. Long-term follow-up of full macular translocation for choroidal neovascularization.
Yamada Y; Miyamura N; Suzuma K; Kitaoka T
Am J Ophthalmol; 2010 Mar; 149(3):453-7.e1. PubMed ID: 20035923
[TBL] [Abstract][Full Text] [Related]
29. Results of one-year's treatment with ranibizumab for exudative age-related macular degeneration in a clinical setting.
Cohen SY; Dubois L; Tadayoni R; Fajnkuchen F; Nghiem-Buffet S; Delahaye-Mazza C; Guiberteau B; Quentel G
Am J Ophthalmol; 2009 Sep; 148(3):409-13. PubMed ID: 19477713
[TBL] [Abstract][Full Text] [Related]
30. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration.
Kaiser PK; Blodi BA; Shapiro H; Acharya NR;
Ophthalmology; 2007 Oct; 114(10):1868-75. PubMed ID: 17628683
[TBL] [Abstract][Full Text] [Related]
31. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.
Fung AE; Lalwani GA; Rosenfeld PJ; Dubovy SR; Michels S; Feuer WJ; Puliafito CA; Davis JL; Flynn HW; Esquiabro M
Am J Ophthalmol; 2007 Apr; 143(4):566-83. PubMed ID: 17386270
[TBL] [Abstract][Full Text] [Related]
32. Intravitreal ranibizumab for choroidal neovascularization complicating pathologic myopia.
Lalloum F; Souied EH; Bastuji-Garin S; Puche N; Querques G; Glacet-Bernard A; Coscas G; Soubrane G; Leveziel N
Retina; 2010 Mar; 30(3):399-406. PubMed ID: 20038864
[TBL] [Abstract][Full Text] [Related]
33. Long-term follow-up of myopic choroidal neovascularization treated with ranibizumab.
Franqueira N; Cachulo ML; Pires I; Fonseca P; Marques I; Figueira J; Silva R
Ophthalmologica; 2012; 227(1):39-44. PubMed ID: 22056757
[TBL] [Abstract][Full Text] [Related]
34. Combination treatment with intravitreal injection of ranibizumab and reduced fluence photodynamic therapy for choroidal neovascularization secondary to angioid streaks: preliminary clinical results of 12-month follow-up.
Artunay O; Yuzbasioglu E; Rasier R; Sengul A; Senel A; Bahcecioglu H
Retina; 2011; 31(7):1279-86. PubMed ID: 21394063
[TBL] [Abstract][Full Text] [Related]
35. Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results.
Yamazaki T; Koizumi H; Yamagishi T; Kinoshita S
Ophthalmology; 2012 Aug; 119(8):1621-7. PubMed ID: 22551738
[TBL] [Abstract][Full Text] [Related]
36. Correlation between subfoveal choroidal thickness and the severity or progression of nonexudative age-related macular degeneration.
Lee JY; Lee DH; Lee JY; Yoon YH
Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7812-8. PubMed ID: 24204054
[TBL] [Abstract][Full Text] [Related]
37. Treatment-Naïve Quiescent Choroidal Neovascularization in Geographic Atrophy Secondary to Nonexudative Age-Related Macular Degeneration.
Capuano V; Miere A; Querques L; Sacconi R; Carnevali A; Amoroso F; Bandello F; Souied EH; Querques G
Am J Ophthalmol; 2017 Oct; 182():45-55. PubMed ID: 28734811
[TBL] [Abstract][Full Text] [Related]
38. Choroidal neovascularization associated with extensive macular atrophy with pseudodrusen-like appearance.
Kamami-Levy C; Querques G; Rostaqui O; Blanco-Garavito R; Souied EH
J Fr Ophtalmol; 2014 Dec; 37(10):780-6. PubMed ID: 25278483
[TBL] [Abstract][Full Text] [Related]
39. Atypical peripapillary location of choroidal neovascularization--case reports.
Figurska M; Wierzbowska J
Klin Oczna; 2009; 111(1-3):56-61. PubMed ID: 19517848
[TBL] [Abstract][Full Text] [Related]
40. Natural History of Geographic Atrophy Secondary to Age-Related Macular Degeneration: Results from the Prospective Proxima A and B Clinical Trials.
Holekamp N; Wykoff CC; Schmitz-Valckenberg S; Monés J; Souied EH; Lin H; Rabena MD; Cantrell RA; Henry EC; Tang F; Swaminathan B; Martin J; Ferrara D; Staurenghi G
Ophthalmology; 2020 Jun; 127(6):769-783. PubMed ID: 32081489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
